It’s earnings season, and companies across North Carolina are reporting financial results for the most recent quarter. Here’s a wrapup:

Qorvo

GREENSBORO – Qorvo Inc. (QRVO) on Wednesday reported fiscal first-quarter profit of $285.6 million.

On a per-share basis, the Greensboro, North Carolina-based company said it had profit of $2.51. Earnings, adjusted for one-time gains and costs, were $2.83 per share.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.45 per share.

The chipmaker posted revenue of $1.11 billion in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $1.08 billion.

For the current quarter ending in October, Qorvo said it expects revenue in the range of $1.24 billion to $1.26 billion.

Qorvo shares have risen 17% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $194.22, an increase of 48% in the last 12 months.

Aerie Pharmaceuticals

DURHAM – Aerie Pharmaceuticals Inc. (AERI) on Wednesday reported a loss of $38.7 million in its second quarter.

The North Carolina, North Carolina-based company said it had a loss of 84 cents per share. Losses, adjusted for non-recurring costs, came to 67 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.

The drugmaker posted revenue of $27.2 million in the period, which topped Street forecasts. Six analysts surveyed by Zacks expected $26.4 million.

Aerie shares have climbed 11% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $15.01, an increase of 29% in the last 12 months.

BioDelivery Sciences

RALEIGH – BioDelivery Sciences International Inc. (BDSI) on Wednesday reported second-quarter profit of $9.1 million.

The Raleigh, North Carolina-based company said it had profit of 9 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 5 cents per share.

The specialty pharmaceutical company posted revenue of $41.4 million in the period, falling short of Street forecasts. Six analysts surveyed by Zacks expected $42 million.

BioDelivery expects full-year revenue in the range of $170 million to $180 million.

The company’s shares closed at $3.90. A year ago, they were trading at $4.45.

VTv Therapeutics

HIGH POINT – VTv Therapeutics Inc. (VTVT) on Wednesday reported a loss of $608,000 in its second quarter.

On a per-share basis, the High Point, North Carolina-based company said it had a loss of 1 cent.

The biopharmaceutical company posted revenue of $9,000 in the period.

In the final minutes of trading on Wednesday, the company’s shares hit $1.96. A year ago, they were trading at $2.49.

First Citizens

RALEIGH – First Citizens BancShares Inc. (FCNCA) on Tuesday reported second-quarter profit of $152.8 million.

The bank, based in Raleigh, North Carolina, said it had earnings of $15.09 per share.

The bank posted revenue of $496 million in the period. Its revenue net of interest expense was $480.5 million, beating Street forecasts.

First Citizens shares have risen 34% since the beginning of the year. The stock has climbed 81% in the last 12 months.